| |
| |
|
| Insider
Information: |
Apple Robert F |
| Relationship: |
President and CEO, Dir... |
| City: |
Blue Bell |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -58.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antares Pharma Inc |
ATRS |
President and CEO, Dir... |
2022-05-24 |
0 |
2007-05-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2017-02-22 |
4 |
D |
$2.37 |
$4,178 |
D/D |
(1,763) |
893,849 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2017-04-05 |
4 |
OE |
$1.65 |
$4,950 |
D/D |
3,000 |
893,002 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2017-04-05 |
4 |
AS |
$3.00 |
$9,000 |
D/D |
(3,000) |
890,002 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-05-28 |
4 |
D |
$2.18 |
$7,388 |
D/D |
(3,389) |
314,870 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2017-05-29 |
4 |
D |
$2.51 |
$8,509 |
D/D |
(3,390) |
875,556 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2014-05-21 |
4/A |
D |
$2.97 |
$10,472 |
D/D |
(3,526) |
340,392 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-05-21 |
4 |
D |
$2.10 |
$7,405 |
D/D |
(3,526) |
318,259 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-02-10 |
4/A |
D |
$2.36 |
$11,278 |
D/D |
(4,779) |
355,455 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-02-10 |
4 |
D |
$2.36 |
$11,278 |
D/D |
(4,779) |
326,619 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2021-02-17 |
4 |
AS |
$4.75 |
$26,215 |
D/D |
(5,519) |
2,446,720 |
0 |
% |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2021-02-17 |
4 |
OE |
$2.62 |
$14,460 |
D/D |
5,519 |
2,452,239 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,612 |
895,612 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2021-02-10 |
4 |
AS |
$4.75 |
$34,571 |
D/D |
(7,278) |
2,295,155 |
0 |
% |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2021-02-10 |
4 |
OE |
$2.62 |
$19,068 |
D/D |
7,278 |
2,302,433 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2013-05-06 |
4 |
AS |
$4.02 |
$40,157 |
D/D |
(10,000) |
301,578 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2013-05-06 |
4 |
OE |
$0.47 |
$4,700 |
D/D |
10,000 |
311,578 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2014-01-10 |
4 |
OE |
$0.47 |
$4,700 |
D/D |
10,000 |
378,918 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2014-01-10 |
4 |
AS |
$5.00 |
$50,000 |
D/D |
(10,000) |
368,918 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2010-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,155 |
156,255 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2010-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,422 |
166,677 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2016-06-30 |
4 |
A |
$1.05 |
$11,784 |
D/D |
11,223 |
869,719 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2014-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
11,236 |
380,154 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2014-02-11 |
4 |
D |
$4.45 |
$50,000 |
D/D |
(11,236) |
343,918 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-02-10 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,519 |
360,234 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & COO |
• – – |
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,519 |
331,398 |
0 |
- |
|
105 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
